Modifiers of Disease Severity in Cerebral Cavernous Malformations | MicrobiomeTrials← Back to trialsNCT01764529
Modifiers of Disease Severity in Cerebral Cavernous Malformations
CompletedOBSERVATIONAL
Trial Details
Start: 2010-04-27Est. Completion: 2025-03-31
Enrollment target: 789 participants Locations- Barrow Neurological Institute, Phoenix, Arizona, United States
- University of California, San Francisco, San Francisco, California, United States
- University of Chicago, Medicine and Biological Sciences, Chicago, Illinois, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
- Cincinnati Children's Hospital, Division of Pediatric Neurosurgery, Cerebrovascular Program, Cincinnati, Ohio, United States
- Alliance to Cure Cavernous Malformation, Charlottesville, Virginia, United States
Other microbiome trials you might be interested in
Cerebral Cavernous Malformation
This is a two-part, multi-center, randomized, double-blind, placebo-controlled study to investigate the safety, efficacy…
Phoenix, United StatesCompleted Jun 30, 2025
Cerebral Cavernous Malformation
This phase I/II randomized, placebo-controlled, double-blinded, single-site clinical trial is designed to investigate th…
Chicago, United StatesCompleted Jul 31, 2024